NEW YORK — Nonprofit research foundation Target ALS said on Tuesday that it has committed $15 million to a newly-launched program focused on the discovery of biomarkers for amyotrophic lateral sclerosis (ALS).
With the funding, the Target ALS Diagnosis Initiative will support new precompetitive and competitive research into ALS biomarker discovery and development.